| Literature DB >> 30859383 |
V Khavinson1,2, S Trofimova1, A Trofimov1, I Solomin3.
Abstract
Retinal diseases were always difficult problem for clinical ophthalmology. Modern methods of their treatment only decrease risk of complications, however in Russia was created better technology for this purpose: peptide bioregulators, which were made by sequential adding of amino acids one to another, binding with the promoter region of genes, and promoting retinoprotective effect by regulation of their expression, improving the state of the retina.Entities:
Keywords: Binding sites; DNA; Peptide bioregulators; Promoter regions; Retinal diseases; Short peptides
Mesh:
Substances:
Year: 2019 PMID: 30859383 DOI: 10.1007/s12015-019-09882-7
Source DB: PubMed Journal: Stem Cell Rev Rep ISSN: 2629-3277 Impact factor: 5.739